Sign In
Buy KMDA
$7.39
-0.120 (-1.60%)
At Close: Jun 03, 2026
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
08:53am, Monday, 09'th Oct 2023
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
Kamada Announces Shareholder Approval and Planned Closing of $60 Million Private Placement with FIMI Opportunity Funds
07:00am, Wednesday, 30'th Aug 2023
REHOVOT, Israel and HOBOKEN, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed product
Kamada Reports Strong Second Quarter and First Half 2023 Financial Results; Reiterates 2023 Revenue and Profitability Guidance
07:00am, Wednesday, 16'th Aug 2023
REHOVOT, Israel and HOBOKEN, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed product
Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial Results and Host Conference Call on August 16, 2023
07:00am, Wednesday, 09'th Aug 2023
REHOVOT, Israel and HOBOKEN, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indica
Kamada: Deep Dive Following FIMI Placement, Rate Buy
05:10am, Wednesday, 21'st Jun 2023
Kamada Ltd. has potential catalysts for growth, capital attraction and regulatory tailwinds. The company's valuation appears attractive, with forward estimates suggesting a possible re-rating. Key ris
Kamada Ltd. (KMDA) Q1 2023 Earnings Call Transcript
01:21pm, Wednesday, 24'th May 2023
Kamada Ltd. (NASDAQ:KMDA ) Q1 2023 Results Earnings Conference Call May 24, 2023 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors, LLC Amir London - Chief Executive
Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023
07:00am, Wednesday, 17'th May 2023
REHOVOT, Israel and HOBOKEN, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicat
Kamada Ltd. (KMDA) Q4 2022 Earnings Call Transcript
04:07pm, Wednesday, 15'th Mar 2023
Kamada Ltd. (NASDAQ:KMDA ) Q4 2022 Earnings Conference Call March 15, 2023 8:30 AM ET Company Participants Troy Williams - LifeSci Advisors Amir London - CEO Chaime Orlev - CFO Conference Call Partici
New Strong Buy Stocks for November 28th
09:02am, Monday, 28'th Nov 2022
KMDA, SLCA and FTNT have been added to the Zacks Rank #1 (Strong Buy) List on November 28, 2022.
Kamada Ltd. (KMDA) Q3 2022 Earnings Call Transcript
10:35am, Tuesday, 22'nd Nov 2022
Kamada Ltd. (NASDAQ:KMDA ) Q3 2022 Earnings Conference Call November 22, 2022 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Amir London - Chief Executive Officer Chaime Orlev - Chief Fi
Kamada (KMDA) Q3 Earnings and Revenues Top Estimates
09:47am, Tuesday, 22'nd Nov 2022
Kamada (KMDA) delivered earnings and revenue surprises of 433.33% and 8.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kamada Ltd. (KMDA) CEO Amir London on Q2 2022 Results - Earnings Call Transcript
01:58pm, Wednesday, 17'th Aug 2022
Kamada Ltd. (NASDAQ:KMDA ) Q2 2022 Earnings Conference Call August 17, 2022 8:30 AM ET Company Representatives Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Bob Yedid -
Kamada (KMDA) Q2 Earnings Beat Estimates
09:47am, Wednesday, 17'th Aug 2022
Kamada (KMDA) delivered earnings and revenue surprises of 450% and 1.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Kamada to Announce Second Quarter and First Half Ended June 30, 2022 Financial Results and Host Conference Call on August 17, 2022
07:00am, Wednesday, 10'th Aug 2022
REHOVOT, Israel and HOBOKEN, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived th
Kamada Ltd. (KMDA) CEO Amir London on Q1 2022 Results - Earnings Call Transcript
11:06am, Tuesday, 17'th May 2022
Kamada Ltd. (NASDAQ:KMDA ) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Amir London - Chief Executive Officer Chaime Orlev - Chief Financi
